This course has expired. View available courses.
Infectious Disease
Eliminating Hepatitis C: What GPs need to know – ACRRM
Hepatitis C virus (HCV) is a potentially life-threatening virus that primarily affects the liver, but is also responsible for extra-hepatic manifestations such as porphyria, increased risk of lymphoma and diabetes. The introduction of direct-acting antiviral (DAA) therapies, which can cure HCV in the majority of patients, represents a major advance – and all Australians living with HCV should now be considered for DAA therapy. However, 121,560 people were estimated to still living be living with chronic HCV at the end of 2019 highlighting the need for improved diagnosis and treatment uptake.
This 1-hour RACGP accredited activity aims to empower GPs to implement a simple, evidence-based approach to identify and manage patients with HCV. It features two cases studies.
This program is supported by an independent and unrestricted educational grant by Gilead.
DURATION
1 hr
PROFESSION
Physician
# OF CREDITS
1
ACCREDITATION
ACRRM
EXPIRY DATE
2022-12-14
Hepatitis C virus (HCV) is a potentially life-threatening virus that primarily affects the liver, but is also responsible for extra-hepatic manifestations such as porphyria, increased risk of lymphoma and diabetes. The introduction of direct-acting antiviral (DAA) therapies, which can cure HCV in the majority of patients, represents a major advance – and all Australians living with HCV should now be considered for DAA therapy. However, 121,560 people were estimated to still living be living with chronic HCV at the end of 2019 highlighting the need for improved diagnosis and treatment uptake.
This 1-hour RACGP accredited activity aims to empower GPs to implement a simple, evidence-based approach to identify and manage patients with HCV. It features two cases studies.
This program is supported by an independent and unrestricted educational grant by Gilead.
Faculty
Associate Professor Stephen Pianko, MBBS, PhD,
Gastroenterologist and Hepatologist, Monash University,
Head of Clinical Trials, Monash Health, Melbourne, Victoria
Dr Annie Balcomb, MBBS, FRACGP, S100 HSV Prescriber,
Part time lecturer, Sydney University,
Orange Rural Medical Campus, Orange, NSW
Professor Alex Thompson, MBBS (hons), PhD, FRACP, FAASLD
Director of Gastroenterology, St. Vincent’s Hospital Melbourne
Learning objectives
On completion of this program, GPs will be better able to:
- Describe the current burden of HCV disease and how Australia is tracking for WHO 2030 HCV elimination goals
- List the benefits of sustained virological response (SVR) in HCV patients highlighting the reduction in HCV disease complications
- Implement a simple, evidence-based approach to identify patients with HCV
- Recommend a suitable treatment approach for individual patients, and counsel patients on their HCV treatment
- Identify patients living with HCV who require referral to specialist services
Accreditation
This PDP Activity is accredited by The Australian College of Rural & Remote Medicine for 1 hour of Educational Activity.
Activity no. XXXXX